Literature DB >> 16945742

Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women.

Abdou Elhendy1, Arend F L Schinkel, Jeroen J Bax, Ron T van Domburg, Roelf Valkema, Elena Biagini, Harm H Feringa, Don Poldermans.   

Abstract

BACKGROUND: Earlier studies have suggested a modest accuracy of stress thallium 201 myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease (CAD) in women. The accuracy of stress MPI with technetium 99m tetrofosmin has not been studied in women. The aim of this study was to assess the accuracy of stress Tc-99m tetrofosmin MPI for the diagnosis and localization of CAD in women. METHODS AND
RESULTS: We studied 88 women who underwent exercise or dobutamine stress Tc-99m tetrofosmin tomography and coronary angiography within 3 months. Significant CAD was defined as a stenosis 50% or greater in diameter in at least 1 major epicardial coronary artery. Myocardial perfusion abnormalities were detected in 44 of 53 patients with significant CAD and in 7 of 35 patients without significant CAD (overall sensitivity, 83% [95% confidence interval (CI), 73%-93%]; specificity, 80% [95% CI, 67%-93%]; and accuracy, 82% [95% CI, 74%-90%]). The sensitivity was 72% (18/25) in patients with single-vessel CAD and 93% (26/28) in patients with multivessel CAD. Perfusion abnormalities were detected in 2 or more vascular distributions in 20 of 28 patients with multivessel CAD and in 4 of 60 patients without multivessel CAD (sensitivity for the identification of multivessel CAD, 71% [95% CI, 55%-88%]; specificity, 93% [95% CI, 86%-98%]; and accuracy, 86% [95% CI, 79%-93%]). The sensitivity, specificity, and accuracy were 82%, 84%, and 83%, respectively, for the diagnosis of CAD in the left anterior descending artery; 77%, 84%, and 81%, respectively, for CAD in the right coronary artery; and 74%, 80%, and 78%, respectively, for CAD in the left circumflex artery.
CONCLUSION: Stress Tc-99m tetrofosmin MPI is an accurate noninvasive technique for the diagnosis and localization of CAD in women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945742     DOI: 10.1016/j.nuclcard.2006.06.128

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  27 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 2.  Dobutamine stress myocardial perfusion imaging in coronary artery disease.

Authors:  Abdou Elhendy; Jeroen J Bax; Don Poldermans
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

3.  Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease.

Authors:  Abdou Elhendy; Arend F L Schinkel; Ron T van Domburg; Jeroen J Bax; Roelf Valkema; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

4.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

5.  Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT.

Authors:  A M Amanullah; D S Berman; R Hachamovitch; H Kiat; X Kang; J D Friedman
Journal:  Am J Cardiol       Date:  1997-07-15       Impact factor: 2.778

6.  Simultaneous dobutamine stress echocardiography and 99mTc-tetrofosmin three-head single-photon emission computed tomography in patients with suspected coronary artery disease.

Authors:  G Barletta; C Gallini; R Del Bene; E Costanzo; F Fantini
Journal:  Coron Artery Dis       Date:  1999-10       Impact factor: 1.439

7.  Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.

Authors:  P Soman; R Taillefer; E G DePuey; J E Udelson; A Lahiri
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

8.  Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenoses and multivessel disease in women versus men.

Authors:  M I Travin; M S Katz; A W Moulton; N J Miele; B L Sharaf; L L Johnson
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 9.  American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease--the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction].

Authors:  Jennifer H Mieres; Leslee J Shaw; Robert C Hendel; D Douglas Miller; Robert O Bonow; Daniel S Berman; Gary V Heller; Jennifer H Mieres; C Noel Bairey-Merz; Daniel S Berman; Robert O Bonow; Jean M Cacciabaudo; Gary V Heller; Robert C Hendel; Maria C Kiess; D Douglas Miller; Donna M Polk; Leslee J Shaw; Paola E Smanio; Mary N Walsh
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

10.  Incremental value of exercise electrocardiography and thallium-201 testing in men and women for the presence and extent of coronary artery disease.

Authors:  A P Morise; G A Diamond; R Detrano; M Bobbio
Journal:  Am Heart J       Date:  1995-08       Impact factor: 4.749

View more
  7 in total

1.  Technetium tetrofosmin myocardial perfusion imaging in women.

Authors:  Ola Akinboboye; Kenneth Nichols
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

2.  Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: a bivariate meta-analysis.

Authors:  Aline Iskandar; Brendan Limone; Matthew W Parker; Andrew Perugini; Hyejin Kim; Charles Jones; Brian Calamari; Craig I Coleman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-11-13       Impact factor: 5.952

3.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

Review 4.  Diagnosing and characterizing coronary artery disease in women: developments in noninvasive and invasive imaging techniques.

Authors:  Vivian G Ng; Stephanie Meller; Suchith Shetty; Alexandra J Lansky
Journal:  J Cardiovasc Transl Res       Date:  2013-08-06       Impact factor: 4.132

Review 5.  Noninvasive assessment of coronary artery disease in women: What's next?

Authors:  Lawrence M Phillips; Jennifer H Mieres
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

6.  Rationale and Design of the CREDENCE Trial: computed TomogRaphic evaluation of atherosclerotic DEtermiNants of myocardial IsChEmia.

Authors:  Asim Rizvi; Bríain Ó Hartaigh; Paul Knaapen; Jonathon Leipsic; Leslee J Shaw; Daniele Andreini; Gianluca Pontone; Subha Raman; Muhammad Akram Khan; Michael Ridner; Faisal Nabi; Alessia Gimelli; James Jang; Jason Cole; Ryo Nakazato; Christopher Zarins; Donghee Han; Ji Hyun Lee; Jackie Szymonifika; Millie J Gomez; Quynh A Truong; Hyuk-Jae Chang; Fay Y Lin; James K Min
Journal:  BMC Cardiovasc Disord       Date:  2016-10-06       Impact factor: 2.298

7.  Physiologic assessment of coronary artery disease by cardiac computed tomography.

Authors:  Minisha Kochar; James K Min
Journal:  Korean Circ J       Date:  2013-07       Impact factor: 3.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.